Home | GSK US
WEBSeptember 11 2024 Statement: Zantac (ranitidine) litigation – Dixon case. September 06 2024 GSK announces positive results from phase III trial of Nucala (mepolizumab) in COPD. View all press releases.
GSK plc - Wikipedia
WEBGSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with global headquarters in London.
Home | GSK
WEBWe are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.
GSKForYou | GSK Patient Assistance Program
WEBLearn how our program can assist you if you need help paying for your GlaxoSmithKline prescription medicines and vaccines, whether you have coverage or not.
Products - GSK
WEBOur portfolio of more than 20 marketed vaccines is one of the industry’s broadest. We deliver over 1.5 million doses of our vaccines every day; and 4 out of 10 infants born each year receive at least one GSK vaccine.
Company | GSK
WEBWe are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together.
Products | GSK US
WEBProducts. Learn more about our product portfolio and how we're prioritizing vaccines and specialty medicines to get ahead of disease together. Below you can find the full A-Z list of our products available in the United States.
Company | GSK US
WEBBy pursuing this purpose together, we have the scale and expertise to positively impact the health of 2.5 billion people by the end of the decade. In doing so, we will deliver stronger and more sustainable growth as a company where people can thrive. Explore our Purpose, strategy and culture.
GSK plc (GSK) Stock Price, News, Quote & History - Yahoo Finance
WEBFind the latest GSK plc (GSK) stock quote, history, news and other vital information to help you with your stock trading and investing.
GlaxoSmithKline To Spin-Off Consumer Healthcare Business By ...
WEBJul 15, 2021 · On June 23, 2021, GlaxoSmithKline plc (NYSE: GSK, $40.45, Market Cap: $101.8 billion) announced that it plans to spin-off its Consumer Healthcare division into a separately listed company.
Skip to content